Share

Networks

Clinical Studies (6)

  • THALASSA : Study aims to assess the safety and efficacy of plitidepsin as a potential treatment for long COVID
  • MERMAIDS 2 : Study aims to assess the prevalence, clinical spectrum, severity, risk factors, management, transmission, and outcomes of SARS-CoV-2 in hospitalized patients, including the risk of hospital-acquired infection and long-term sequelae
  • Pruñonosa : Study aims to evaluate the safety and tolerability of plasma exchange in patients with Post Acute Covid-19 Syndrome comparing to sham plasma exchange
  • MoVIHvax : Study aims to characterise vaccine-induced responses against mpox infection in people living with HIV and people living without HIV
  • GCAT : Study aims to describe whether COVID-19 severity and postacute sequelae of COVID-19 are associated with differential antibody responses to common viruses in a population-based study of middle-aged adults in Catalonia, Spain
  • E-APLICOV-PC : Study aims to evaluate the impact of plitidepsin treatment on reducing viral load and accelerating patient recovery following SARS-CoV-2 infection. To assess whether this treatment could have a relevant impact on the emergence of long-term sequelae resulting from the infection

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Hospital
  • Outpatient clinic
  • Emergency department
  • Non-hospital health centre
  • STD/STI clinic
  • SARS-CoV-2
  • Monkeypox virus
  • Post COVID-19 condition
  • Acute COVID-19
  • Mpox
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood
  • Pharmacological intervention
  • Non pharmacological intervention
  • Antivirals
  • Plitidepsin
  • Antineoplastic agent
  • Plasma exchange

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to